Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nusinersen (Spinraza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Romiplostim(Nplate) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Noninvasive Imaging Techniques for Evaluation and Monitoring of Chronic Liver Diseases | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Non-invasive Positive Pressure Ventilators (In-Home Use) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Non-Contact Ultrasound Treatment for Wounds | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nonfamilial Genetic Testing for Breast Cancer Risk Assessment | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nivolumab/Relatlimab-rmbw (Opdualag) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nivolumab (Opdivo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Next-Generation Sequencing for the Assessment of Measurable Residual Disease | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nerve Graft with Radical Prostatectomy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Remote Electrical Neuromodulation (REN) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Negative Pressure Wound Therapy in the Outpatient Setting | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Nedosiran (Rivfloza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Necitumumab (Portrazza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Natalizumab (Tysabri), Natalizumab-sztn (Tyruko) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Myocardial Sympathetic Innervation Imaging for Individuals with Heart Failure | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | RimabotulinumtoxinB (Myobloc) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Multiple Sclerosis Products:(Ocrelizumab [Ocrevus], Ocrelizumab and Hyaluronidase-ocsq [Ocrevus Zunovo], Ublituximab-xiiy [Briumvi]) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Multi-biomarker Testing for Rheumatoid Arthritis | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | MRI-guided Laser-induced Thermotherapy for Neurological Indications | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Tafasitamab-cxix (Monjuvi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Molecular Markers in Fine Needle Aspirates of the Thyroid | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mogamulizumab-kpkc (Poteligeo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mitomycin (Zusduri) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mirikizumab-mrkz (Omvoh) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Microwave Ablation for Oncologic Tumors | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Microprocessor-Controlled Prostheses for the Lower Limb | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Vestronidase Alfa-vjbk(Mepsevii) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mepolizumab (Nucala) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mechanized Axial Spinal Distraction Therapy Devices | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mastectomy for Gynecomastia | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | FDA-Approved Indications | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Manipulation Under Anesthesia (MUA) of the Musculoskeletal System | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mammography | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Reduction Mammaplasty (Non-Cancerous) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Pneumatic Compression Pumps | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lymphatic Physiologic Microsurgery for Breast Cancer-Related Lymphedema | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Voretigene Neparvovec-rzyl (Luxturna) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lutetium Lu 177 Vipivotide Tetraxetan (Pluvicto) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Luspatercept-aamt (Reblozyl) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lurbinectedin (Zepzelca) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mosunetuzumab-axgb (Lunsumio, Lunsumio Velo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Low-Dose Radiotherapy for Non-Oncologic Indications | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lovotibeglogene Autotemcel (Lyfgenia) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Toripalimab-tpzi (Loqtorzi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Loncastuximab Tesirine-lpyl (Zynlonta) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Liposuction | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Liposuction and Lipectomy for Lipedema | Criteria changed |